Atlas Trials

Melphalan Hydrochloride in Treating Participants With Newly-Diagnosed Multiple Myeloma Undergoing Donor Stem Cell Transplantation

Clinical trial NCT03417284 · COMPLETED

Trial details

NCT number
NCT03417284
Sponsor
M.D. Anderson Cancer Center
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Plasma Cell Myeloma
Start date
2019-10-09
Primary completion
2024-07-18
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.